Evidence map›Paper›PMID 33337962›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2021

TNF-α-induced sympathetic excitation requires EGFR and ERK1/2 signaling in cardiovascular regulatory regions of the forebrain.

Shun-Guang Wei, Yang Yu, Robert B Felder

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Angiotensin II inhibits the A-type KAmerican journal of physiology. Regulatory, integrative and comparative physiology · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shun-Guang WeiDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.ORCID 0000-0003-4404-4059
Yang YuDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Robert B FelderDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.ORCID 0000-0002-1880-2605
University of Iowa · US

Funding

Novel Role of Interleukin-17 in Sympathetic Activation in Heart FailureR01HL155091 · NHLBI · UNIVERSITY OF IOWA · PI WEI, SHUNGUANG · 2021 to 2025
$2.9M
Brain ERK1/2 Signaling and Sympathetic Excitation in Heart FailureR01HL136149 · NHLBI · UNIVERSITY OF IOWA · PI FELDER, ROBERT B · 2017 to 2020
$2.1M
Targeting TACE, a novel approach to the treatment of sympathetic excitation in heart failure.R01HL139521 · NHLBI · UNIVERSITY OF IOWA · PI WEI, SHUNGUANG · 2018 to 2022
$1.9M
Brain MAP Kinases - Substrate for Sympathetic Excitation in Heart FailureR01HL096671 · NHLBI · UNIVERSITY OF IOWA · PI FELDER, ROBERT B · 2011 to 2014
$1.5M
NHLBI NIH HHS R01 HL096671NHLBI NIH HHS R01 HL136149NHLBI NIH HHS R01 HL139521NHLBI NIH HHS R01 HL155091
6 · The paper itself

Abstract

Peripherally or centrally administered TNF-α elicits a prolonged sympathetically mediated pressor response, but the underlying molecular mechanisms are unknown. Activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in cardiovascular regions of the brain has recently been recognized as a key mediator of sympathetic excitation, and ERK1/2 signaling is induced by activation of epidermal growth factor receptor (EGFR) tyrosine kinase activity. The present study examined the role of EGFR and ERK1/2 signaling in the sympathetic response to TNF-α. In urethane-anesthetized rats, intracarotid artery injection of TNF-α increased phosphorylation of EGFR and ERK1/2 in the subfornical organ (SFO) and the hypothalamic paraventricular nucleus (PVN); upregulated the gene expression of excitatory mediators in SFO and PVN; and increased blood pressure (BP), heart rate (HR), and renal sympathetic nerve activity (RSNA). A continuous intracerebroventricular infusion of the selective EGFR tyrosine kinase inhibitor AG1478 or the ERK1/2 inhibitor PD98059 significantly attenuated these responses. Bilateral PVN microinjections of TNF-α also increased phosphorylated ERK1/2 and the gene expression of excitatory mediators in PVN, along with increases in BP, HR, and RSNA, and these responses were substantially reduced by prior bilateral PVN microinjections of AG1478. These results identify activation of EGFR in cardiovascular regulatory regions of the forebrain as an important molecular mediator of TNF-α-driven sympatho-excitatory responses and suggest that EGFR activation of the ERK1/2 signaling pathway plays an essential role. These mechanisms likely contribute to sympathetic excitation in pathophysiological states like heart failure and hypertension, in which circulating and brain TNF-α levels are increased.

Indexed as

AnimalsBlood PressureCardiovascular SystemErbB ReceptorsHeart RateHemodynamicsMaleMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhosphorylationProsencephalonProtein Kinase InhibitorsQuinazolinesRatsRats, Sprague-DawleySignal TransductionEgfr protein, ratErbB ReceptorsMapk1 protein, ratMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Protein Kinase InhibitorsQuinazolinesRTKI cpdTumor Necrosis Factor-alphaTyrphostinsbrainhypothalamic paraventricular nucleusproinflammatory cytokinesrenin-angiotensin systemsubfornical organsympathetic nervous system

Identifiers

PMID33337962
PMCPMC8082799
OpenAlexW3117652620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.